SEC Form 4 · accession 0001437749-19-000994

FACTSET RESEARCH SYSTEMS INC · FDS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

John W. Wiseman

Officer — EVP, Global Head of Sales

Period of report

Jan 15, 2019

Accepted (ET)

Jan 17, 2019 · 5:16 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001013237

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jan 15, 2019	M	210	$92.22	A	2,050	D
Common Stock	Jan 15, 2019	M	612	$92.22	A	2,662	D
Common Stock	Jan 15, 2019	M	72	$94.84	A	2,734	D
Common Stock	Jan 15, 2019	M	1,990	$131.31	A	4,724	D
Common Stock	Jan 15, 2019	M	1,827	$152.28	A	6,551	D
Common Stock	Jan 15, 2019	M	800	$159.14	A	7,351	D
Common Stock	Jan 15, 2019	M	3,608	$160.58	A	10,959	D
Common Stock^F1	Jan 15, 2019	S	6,094	$205.56	D	4,865	D
Common Stock^F2	Jan 15, 2019	S	3,025	$206.23	D	1,840	D
Common Stock	Jan 15, 2019	S	240	$205.02	D	1,600	D
Common Stock^F3	Jan 15, 2019	S	310	$205.39	D	1,290	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F4	$92.22	Jan 15, 2019	M	210	D	—	Nov 1, 2022	Common Stock	210	0	D
Employee Stock Option (right to buy)^F5	$92.22	Jan 15, 2019	M	612	D	—	Nov 1, 2022	Common Stock	612	0	D
Employee Stock Option (right to buy)^F6	$94.84	Jan 15, 2019	M	72	D	—	Nov 1, 2021	Common Stock	72	0	D
Employee Stock Option (right to buy)^F7	$131.31	Jan 15, 2019	M	1,990	D	—	Nov 3, 2024	Common Stock	1,990	1,328	D
Employee Stock Option (right to buy)^F8	$152.28	Jan 15, 2019	M	1,827	D	—	Nov 1, 2026	Common Stock	1,827	2,737	D
Employee Stock Option (right to buy)^F9	$159.14	Jan 15, 2019	M	800	D	—	May 1, 2025	Common Stock	800	534	D
Employee Stock Option (right to buy)^F10	$160.58	Jan 15, 2019	M	3,608	D	—	Jul 6, 2027	Common Stock	3,608	14,425	D

Explanation of responses

F1Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 6,094, the per share sales prices ranged from $205.10 to $206.09. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4.
F10Options granted on July 6, 2017 vest 20% annually on the anniversary date of the grant and are fully vested after five years.
F2Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 3,025, the per share sales prices ranged from $206.10 to $206.48. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4.
F3Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 310, the per share sales prices ranged from $205.38 to $205.51. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4.
F4Options granted on November 1, 2012 vest over a 5 year period with 40% exercisable two years after the grant date and the remainder vesting at a rate of 1.67% per month thereafter.
F5Options granted on November 1, 2012 vest over a 5 year period with 20% exercisable one year after the grant date and the remainder vesting at a rate of 1.67% per month thereafter.
F6Options granted on November 1, 2011 vest over a 5 year period with 20% exercisable one year after the grant date and the remainder vesting at a rate of 1.67% per month thereafter.
F7Options granted on November 3, 2014 vest over a 5 year period with 60% exercisable three years after the grant date and the remaining 40% vesting five years after the grant date.
F8Options granted on November 1, 2016 vest 20% annually on the anniversary date of the grant and are fully vested after five years.
F9Options granted on May 1, 2015 vest over a 5 year period with 60% exercisable three years after the grant date and the remaining 40% vesting five years after the grant date.